ARCHIVES

Reimbursement Policy By Philadelphia Blue Cross Further Explained

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Rimer, Boxer Reappointed to NCAB; 4 Others Named

June 28, 1996

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014